RecensMedical, Inc. (KOSDAQ:394420)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,250
+490 (5.02%)
At close: Sep 4, 2026

RecensMedical Statistics

Total Valuation

RecensMedical has a market cap or net worth of KRW 112.75 billion. The enterprise value is 105.05 billion.

Market Cap112.75B
Enterprise Value 105.05B

Important Dates

The next estimated earnings date is Friday, November 13, 2026.

Earnings Date Nov 13, 2026
Ex-Dividend Date n/a

Share Statistics

RecensMedical has 11.00 million shares outstanding. The number of shares has increased by 186.73% in one year.

Current Share Class 11.00M
Shares Outstanding 11.00M
Shares Change (YoY) +186.73%
Shares Change (QoQ) +15.61%
Owned by Insiders (%) 20.25%
Owned by Institutions (%) 8.93%
Float 6.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 17.29
PB Ratio 5.68
P/TBV Ratio 5.73
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 16.11
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.30.

Current Ratio 4.02
Quick Ratio 2.95
Debt / Equity 0.30
Debt / EBITDA n/a
Debt / FCF -0.48
Interest Coverage -64.35

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -49.90%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 12,727.20
200-Day Moving Average n/a
Relative Strength Index (RSI) 35.43
Average Volume (20 Days) 132,195

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RecensMedical had revenue of KRW 6.52 billion and -11.05 billion in losses. Loss per share was -1,125.66.

Revenue6.52B
Gross Profit 3.47B
Operating Income -11.74B
Pretax Income -11.05B
Net Income -11.05B
EBITDA -11.12B
EBIT -11.74B
Loss Per Share -1,125.66
Full Income Statement

Balance Sheet

The company has 13.67 billion in cash and 5.98 billion in debt, with a net cash position of 7.70 billion or 699.64 per share.

Cash & Cash Equivalents 13.67B
Total Debt 5.98B
Net Cash 7.70B
Net Cash Per Share 699.64
Equity (Book Value) 19.86B
Book Value Per Share 1,819.21
Working Capital 18.84B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.27 billion and capital expenditures -1.14 billion, giving a free cash flow of -12.40 billion.

Operating Cash Flow -11.27B
Capital Expenditures -1.14B
Depreciation & Amortization 621.70M
Net Borrowing 4.62B
Free Cash Flow -12.40B
FCF Per Share -1,127.46
Full Cash Flow Statement

Margins

Gross margin is 53.25%, with operating and profit margins of -180.08% and -169.40%.

Gross Margin 53.25%
Operating Margin -180.08%
Pretax Margin -169.40%
Profit Margin -169.40%
EBITDA Margin -170.54%
EBIT Margin -180.08%
FCF Margin n/a

Dividends & Yields

RecensMedical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -186.73%
Shareholder Yield -186.73%
Earnings Yield -9.80%
FCF Yield -11.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RecensMedical has an Altman Z-Score of 9.73 and a Piotroski F-Score of 2.

Altman Z-Score 9.73
Piotroski F-Score 2